Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 100.89 USD -1.35% Market Closed
Market Cap: 250.4B USD

Gross Margin
Merck & Co Inc

78.7%
Current
75%
Average
48.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.7%
=
Gross Profit
50.6B
/
Revenue
64.2B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
US
Merck & Co Inc
NYSE:MRK
250.9B USD
79%
US
Eli Lilly and Co
NYSE:LLY
959.5B USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
487.2B USD
68%
CH
Roche Holding AG
SIX:ROG
246.1B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP
82%
CH
Novartis AG
SIX:NOVN
205.7B CHF
76%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
82%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
68%
US
Pfizer Inc
NYSE:PFE
146.1B USD
75%
FR
Sanofi SA
PAR:SAN
103.1B EUR
72%
No Stocks Found

Merck & Co Inc
Glance View

Nestled in the heart of the pharmaceutical industry, Merck & Co., Inc. stands as a titan of innovation and healthcare. Established in 1891, the company has grown and evolved, driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. At the core of Merck’s operations is its commitment to research and development (R&D), which serves as the lifeblood of its product pipeline. With billions poured annually into R&D, Merck seeks to uncover new medical breakthroughs that address unmet medical needs across diverse therapeutic areas, such as oncology, vaccines, infectious diseases, and diabetes. This relentless pursuit of scientific advancement is not only a testament to Merck’s commitment to health but also a critical factor in maintaining its competitive edge in a crowded market. Merck's business model is elegantly straightforward yet highly structured. Primarily, the company's revenue streams are powered by the sales of prescription medications and vaccines that emerge from their exhaustive research efforts. Products like Keytruda, a cancer immunotherapy, and Gardasil, a vaccine for human papillomavirus, are standout performers, championing Merck's ability to penetrate high-value markets and secure regulatory approvals across the globe. Beyond the development and sale of pharmaceuticals, Merck generates additional revenue through collaborations and partnerships with other companies, leveraging co-development and marketing agreements to extend its reach. Underpinning Merck's financial model is its rigorous approach to cost management and strategic acquisitions, which bolster its robust product line-up and keep the engines of growth humming. This strategic orchestration ensures that while Merck fulfills its corporate mission, it also aligns with shareholder interests, reflecting a harmonious balance that has supported its storied legacy.

MRK Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.7%
=
Gross Profit
50.6B
/
Revenue
64.2B
What is the Gross Margin of Merck & Co Inc?

Based on Merck & Co Inc's most recent financial statements, the company has Gross Margin of 78.7%.

Back to Top